US ready to help China with vaccines to control Covid: State Secy Blinken

"We want to see China get this outbreak under control," Blinken told a press conference

Antony Blinken, US Secretary of State
US Secretary of State Antony Blinken | Photo: Bloomberg
Courtney McBride | Bloomberg
2 min read Last Updated : Dec 23 2022 | 8:38 AM IST
The US is prepared to help China with vaccines to help address its Covid-19 outbreak, but the government in Beijing hasn’t asked for assistance so far, Secretary of State Antony Blinken said.
 
“We want to see China get this outbreak under control,” Blinken told a press conference. He said the US is worried about the rise of new coronavirus variants and said China’s outbreak has “clear implications for the global economy because of China being shut down on multiple levels.”

After trying to eliminate Covid-19 for three years, China is now letting it circulate widely. The move has resulted in an explosion in cases and reports of uncounted coronavirus deaths are mounting. One problem is that many older Chinese people aren’t vaccinated, while another is that China still hasn’t approved any foreign vaccines including mRNA-based options from BioNTech or Moderna, for its own population.

Liu Pengyu, a spokesman for the Chinese Embassy in Washington, said in a statement that the nation’s vaccine stock “can generally meet demand” and boosters were being rolled out. Chinese and American health officials will stay in touch, he added.

Blinken did not respond to questions about the validity of Beijing’s official tally of casualties in the current outbreak, but stressed the importance of transparency.

It’s important “for all countries, including China, to focus on people getting vaccinated, making testing and treatment available, and importantly, sharing information with the world about what they’re experiencing,” Blinken said. “Again, because it has implications not just for China, but for the entire world.”

During the same press conference, Blinken touted US efforts to increase Covid-19 vaccination worldwide and to help countries prepare for future pandemics.

(Updates with comments from China’s Embassy in fourth paragraph.)

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusUSAChinaAntony BlinkenCoronavirus Vaccine

Next Story